| 2026-06-04 | 8-K | 10.1 | Amended and Restated 2024 Equity Incentive Plan. |
|---|
| 2026-03-30 | 8-K | 10.2 | Form of Registration Rights Agreement |
|---|
| 2026-03-30 | 8-K | 10.1 | Form of Securities Purchase Agreement |
|---|
| 2026-03-12 | 10-K | 10.18 | OnKure Therapeutics, Inc. Outside Director Compensation Policy. |
|---|
| 2024-10-08 | 8-K | 10.23 | Registration Rights Agreement dated October 4, 2024 by and among OnKure Therapeutics, Inc. and certain parties thereto. |
|---|
| 2024-10-08 | 8-K | 10.22 | Form of Indemnification Agreement |
|---|
| 2024-10-08 | 8-K | 10.21 | OnKure Therapeutics, Inc. Outside Director Compensation Policy. |
|---|
| 2024-10-08 | 8-K | 10.20 | OnKure Therapeutics, Inc. Form of Executive Employment Agreement. |
|---|
| 2024-10-08 | 8-K | 10.19 | OnKure Therapeutics, Inc. Executive Incentive Compensation Plan. |
|---|
| 2024-10-08 | 8-K | 10.18 | OnKure, Inc. 2023 RSU Equity Incentive Plan, and forms of agreement thereunder. |
|---|
| 2024-10-08 | 8-K | 10.17 | OnKure, Inc. 2021 Stock Incentive Plan, as amended, and forms of agreement thereunder. |
|---|
| 2024-10-08 | 8-K | 10.16 | OnKure, Inc. 2011 Stock Incentive Plan, as amended, and forms of agreement thereunder. |
|---|
| 2024-10-08 | 8-K | 10.15 | OnKure Therapeutics, Inc. 2024 Employee Stock Purchase Plan. |
|---|
| 2024-10-08 | 8-K | 10.14 | OnKure Therapeutics, Inc. 2024 Equity Incentive Plan, and forms of agreement thereunder. |
|---|
| 2024-08-13 | 10-Q | 10.5 | Consulting Agreement, dated May 10, 2024, by and between the Registrant and Ashley F. Hall, J.D. |
|---|
| 2024-08-13 | 10-Q | 10.4 | Consulting Agreement, dated May 10, 2024, by and between the Registrant and Michael P. Cruse. |
|---|
| 2024-08-13 | 10-Q | 10.3 | Consulting Agreement, dated May 10, 2024, by and between the Registrant and Alejandro Dorenbaum, M.D. |
|---|
| 2024-08-13 | 10-Q | 10.2 | Consulting Agreement, dated May 10, 2024, by and between the Registrant and Gregory J. Flesher. |
|---|
| 2024-05-13 | 8-K | 10.6 | Form of Consulting Agreement |
|---|
| 2024-05-13 | 8-K | 10.5 | Letter Agreement by and between Reneo Pharmaceuticals, Inc. and Jennifer Lam |
|---|
| 2024-05-13 | 8-K | 10.4 | Subscription Agreement dated May 10, 2024 |
|---|
| 2024-05-13 | 8-K | 10.3 | Form of Lock-Up Agreement (included as Exhibit E in Exhibit 2.1) |
|---|
| 2024-05-13 | 8-K | 10.2 | Form of OnKure Support Agreement (included as Exhibit D-1 in Exhibit 2.1) |
|---|
| 2024-05-13 | 8-K | 10.1 | Form of Reneo Support Agreement (included as Exhibit C in Exhibit 2.1) |
|---|
| 2023-11-13 | 10-Q | 10.1 | Sales Agreement, dated November 13, 2023, by and between the Registrant and Leerink Partners LLC. |
|---|
| 2023-05-05 | 8-K | 10.1 | Securities Purchase Agreement, dated as of May 2, 2023, by and between Reneo Pharmaceuticals, Inc. and Abingworth Bioventures 8 LP |
|---|
| 2023-03-27 | 10-K | 10.18 | Forms of (i) Stock Option Grant Notice, Stock Option Agreement and Notice of Exercise, (ii) Stock Option Grant Notice - International, Stock Option Agreement - International and Notice of Exercise - International and (iii) Non-Employee Director Stock Option Grant Notice, Stock Option Agreement and Notice of Exercise – Non-Employee Director under the Reneo Pharmaceuticals, Inc. 2021 Equity Incentive Plan. |
|---|
| 2023-03-27 | 10-K | 10.9 | Reneo Pharmaceuticals, Inc. Non-Employee Director Compensation Policy, as amended. |
|---|
| 2022-11-08 | 10-Q | 10.2 | Letter Agreement by and between the Registrant and Roshawn Blunt, dated August 2, 2022 (incorporated by reference to Exhibit 10.2 to the Registrant’s Quarterly Report on Form 10-Q, filed with the SEC on August 9, 2022). |
|---|
| 2022-08-09 | 10-Q | 10.2 | Letter Agreement by and between the Registrant and Roshawn Blunt, dated August 2, 2022. |
|---|
| 2022-03-23 | 10-K | 10.14 | Transition, Separation and Consulting Agreement by and between the Registrant and Vineet R. Jindal, dated February 2, 2022. |
|---|
| 2022-03-23 | 10-K | 10.13 | Letter Agreement by and between Registrant and Paul W. Hoelscher, dated January 20, 2022. |
|---|
| 2022-03-23 | 10-K | 10.12 | Transition, Separation and Consulting Agreement by and between the Registrant and Wendy Johnson, dated December 23, 2021. |
|---|
| 2022-03-23 | 10-K | 10.11 | Reneo Pharmaceuticals, Inc. 2021 Non-Employee Director Compensation Policy, as amended. |
|---|
| 2021-11-12 | 10-Q | 10.5 | Forms of RSU Award Grant Notice and Award Agreement (RSU Award) for Inducement Grant Outside of the Reneo Pharmaceuticals, Inc. 2021 Equity Incentive Plan. |
|---|
| 2021-11-12 | 10-Q | 10.4 | Forms of Stock Option Grant Notice, Stock Option Agreement and Notice of Exercise for Inducement Grant Outside of the Reneo Pharmaceuticals, Inc. 2021 Equity Incentive Plan. |
|---|
| 2021-11-12 | 10-Q | 10.3 | Reneo Pharmaceuticals, Inc. UK Sharesave Sub-Plan to the Reneo Pharmaceuticals, Inc. 2021 Employee Stock Purchase Plan. |
|---|
| 2021-11-12 | 10-Q | 10.2 | Reneo Pharmaceuticals, Inc. Severance Benefit Plan, as amended, and form of Participation Agreement thereunder. |
|---|
| 2021-11-12 | 10-Q | 10.1 | Employment Agreement by and between the Registrant and Ashley F. Hall, J.D., dated October 11, 2021. |
|---|